Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Running down, running out...

From what I recall, these MMP patents only have a few more years of life, do they not?

As these MMP assets run down the clock, and these lawsuits run PTSC out of money, who is the ultimate beneficiary? If a third party loans PTSC operating capital in exchange for stock, at some point PTSC no longer owns any worthwhile share of MMP. Is that what's happening? Could there be hypothetically be a possibility for external parties to drain PTSC and thus take over full ownership of MMP and then, and only then, forcefully seek high-value licenses before the patents expire? Hypothetically.

Share
New Message
Please login to post a reply